Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for business professionals · Friday, December 14, 2018 · 471,129,327 Articles · 3+ Million Readers

Unique and unrivalled opportunity where the Controlled Release Delivery industry comes together

Controlled Release Delivery 2018

Where the Controlled Release Delivery industry comes together to discuss the latest innovations made within controlled release.

LONDON, WESTMINSTER, UNITED KINGDOM, February 13, 2018 /EINPresswire.com/ -- 13.02.2018

It gives SMi Group great pleasure to invite you to SMi’s 15th annual Controlled Release Delivery conference. Returning to London on the 21st and 22nd of March 2018, this year’s event is a unique and unrivalled opportunity where the industry comes together to discuss the latest innovations made within controlled release, debate the latest regulations and explore how to overcome current challenges together.

With so much going on at this year’s event…can you afford to miss it?
The agenda is packed with keynote addresses, expert speakers, informative content and senior figures from within the industry. Hear from the likes of Colorcon, Grunenthal, GSK, Ipsen, PLIVA, SiTech Pharmabio and more as we hold candid conversations on innovations in drug delivery, nanoparticles/nanomedicine & QbD, CNS drug delivery and therapeutic application.

Here are some of the 2018 event highlights
What you can hear and learn about:
•Formulation of control release delivery (CRD) technologies and improving the design of new CRD systems
•Innovative additions to Oral CRD technologies to improve pharmacokinetic and pharmacodynamic properties of the drug
•Clinical developments and lessons learnt during clinical trials - case studies with top pharmaceutical companies
•Latest regulation guidance and their implications for the pharmaceutical industry

Day 1
Opening Address – Advances in Non-Invasive Routes of Administration of Peptides: Focus on Successful Oral Technologies Progressing in the Clinical – Joel Richards, Ipsen
Keynote Address – Impact of the Current EU Guideline EMA/CPMP/EWP/208/96/Corr 1 on the Pharmacokinetic and Clinical Evaluation of Modified Release Dosage Forms of Generic Drug Product, Pavel Farkas of PLIVA.
In addition, you will hear a number of other presentations covering subjects such as: Innovations and Advances with Peptides, Regulatory Considerations and Developing New Formulations.

Day 2
Opening Address - Emergence of 3D Printed Dosage Forms: Opportunities and Challenges, Mohamed A. Alhnan of University of Central Lancashire.
Keynote Address – The Guardian Technology – Injection Molding of Tablets presented by Larsten Lindhardt of Egalet Corp.
In addition to the above, there will be a number of other presentation covering topics such as: Advances in Coatings & Capsules and Utilisation of Technology & Nanoparticles.

You can view the most up-to-date event brochure online as well as complete your online registration online at www.controlledreleasedelivery.com/PR14EIN



---ENDS---



About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Alan Caddick
Mr.
2087826038
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release